|
| +ve Anti NCS (n=153) | −ve Anti NCS (n = 47) | Chi-square test | |
| X2 | p | |||
| Fatigue | 46.7% | 16.7% | 0.52 | 0.47 |
| Alopecia | 46.7% | 15.0% | 0.053 | 0.82 |
| Photosensitivity | 41.7% | 15.0% | 0.43 | 0.51 |
| Malar rash | 41.7% | 15.0% | 0.43 | 0.51 |
| Arthralgia | 33.3% | 6.7% | 0.99 | 0.32 |
| Arthritis | 23.3% | 10.0% | 0.75 | 0.39 |
| Fever | 21.7% | 5.0% | 0.26 | 0.61 |
| Pulmonary disease | 20.0% | 8.3% | 0.49 | 0.48 |
| Renal disease | 38.3% | 5.0% | 1.17 | 0.28 |
| Weight loss | 21.7% | 3.3% | 1.1 | 0.29 |
| Oral ulcer | 21.7% | 3.3% | 1.1 | 0.29 |
| Vasculitis | 20.0% | 5.0% | 0.12 | 0.72 |
| CNS affection | 18.3% | 1.7% | 1.89 | 0.17 |
| Discoid lesions | 13.3% | 5.0% | 0.12 | 0.37 |
| Cardiac affection | 10.0% | 3.3% | 0.014 | 0.91 |
| GIT affection | 11.7% | 1.7% | 0.61 | 0.44 |
| Decreased Appetite | 6.7% | 1.7% | 0.034 | 0.85 |
| Sore throat | 5.0% | - | 0.96 | 0.33 |